Extract

This trial is conducted in Europe. The aim of this trial is to test if there is bioequivalence between the insulin aspart 100 U/mL (U100) formulation and the new insulin aspart 200 U/mL (U200) formulation.

Inclusion criteria

• diabetes ,Healthy

Links

• nct
• ictrp